The members of Komvos-Node warmly thank DEMO ABEE for the generous sponsorship of the conference titled “Health-Biotechnology and Economy Synergy Structures: Research Institutions, Hospitals, Biotechnology Parks, Industry.”

DEMO ABEE, a leading company in the pharmaceutical industry, is currently implementing a multifaceted investment plan of €356 million, focusing on strengthening its international position and entering high-growth sectors such as the development and production of raw materials and biosimilar drugs. As part of this plan, DEMO ABEE is creating from scratch the Pharmaceutical Biotechnology Production sector in Greece, as it is the first company in Greece to enter the biotechnology field, with the creation of a modern Biotechnology Research Center in Agios Stefanos, Attica, and the commencement of Research & Development for 3 monoclonal antibodies by 2027.

This is therefore a true sponsorship, in the sense that the roundtable discussion at the conference organized for the Node by Konstantinos Drosatos (University of Cincinnati, USA, and Secretary-General of the Board of Directors of Komvos-Node) and Nikos Kyrpides (Berkeley National Laboratory, USA, and Member of the Board of Directors of Komvos-Node), among other topics, will discuss the possibilities and prospects of connecting and collaborating between science and the economy in the biotechnology sector.

Of course, Komvos-Node also thanks the international BIO3 conference, within the framework of which this event is hosted.